基于超声的深度学习影像组学列线图评估浸润性乳腺癌淋巴血管侵犯:一项多中心研究
这项多中心回顾性研究纳入8家医院832例病理确诊浸润性乳腺癌患者,基于B型超声和彩色多普勒血流成像提取深度学习与手工影像组学特征,构建深度学习影像组学列线图术前评估淋巴血管侵犯状态。列线图在训练集、内部测试集和外部测试集的AUC分别为0.93、0.91和0.91,校准良好,性能优于临床模型和单一评分。
要点
- 基于B型超声和彩色多普勒血流成像的深度学习影像组学列线图可用于术前评估浸润性乳腺癌淋巴血管侵犯状态。
- 列线图在训练集、内部测试集和外部测试集的AUC分别为0.93、0.91和0.91,校准良好。
- 列线图性能在所有三个数据集中均优于临床模型和单一评分(p < 0.05)。
核心结论
- 深度学习影像组学列线图对浸润性乳腺癌淋巴血管侵犯表现出较强的预测价值,可为个体化治疗决策提供有价值的信息。
研究设计与样本
- 多中心回顾性研究,纳入8家医院832例病理确诊的浸润性乳腺癌患者,样本分为训练集、内部测试集和外部测试集,基于B型超声和彩色多普勒血流成像提取深度学习与手工影像组学特征。
关键影像表现/征象
- 从B型超声和彩色多普勒血流成像图像中提取反映肿瘤表型的深度学习与手工影像组学特征,经特征选择后计算B型超声评分和彩色多普勒血流成像评分。
- 基于上述评分及独立临床-超声风险变量构建深度学习影像组学列线图。
诊断标准与关键数值
- 列线图预测淋巴血管侵犯的AUC在训练集为0.93(95% CI 0.90-0.95),内部测试集为0.91(95% CI 0.87-0.95),外部测试集为0.91(95% CI 0.86-0.94)。
- 列线图在所有三个数据集中性能均优于临床模型和单一评分(p < 0.05)。
- 决策曲线分析和临床影响曲线证实模型的临床实用性;净重分类改善和综合判别改善显著提升,提示两个评分可作为评估淋巴血管侵犯的高价值生物标志物。
临床应用与阅片要点
- 列线图可用于浸润性乳腺癌患者术前淋巴血管侵犯状态的无创评估,辅助个体化治疗决策。
- 列线图基于B型超声和彩色多普勒血流成像图像构建,性能优于临床模型和单一评分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The aim of this study was to develop a deep learning radiomics nomogram (DLRN) based on B-mode ultrasound (BMUS) and color doppler flow imaging (CDFI) images for preoperative assessment of lymphovascular invasion (LVI) status in invasive breast cancer (IBC).
MATERIALS AND METHODS: In this multicenter, retrospective study, 832 pathologically confirmed IBC patients were recruited from eight hospitals. The samples were divided into training, internal test, and external test sets. Deep learning and handcrafted radiomics features reflecting tumor phenotypes on BMUS and CDFI images were extracted. The BMUS score and CDFI score were calculated after radiomics feature selection. Subsequently, a DLRN was developed based on the scores and independent clinic-ultrasonic risk variables. The performance of the DLRN was evaluated for calibration, discrimination, and clinical usefulness.
RESULTS: The DLRN predicted the LVI with accuracy, achieving an area under the receiver operating characteristic curve of 0.93 (95% CI 0.90-0.95), 0.91 (95% CI 0.87-0.95), and 0.91 (95% CI 0.86-0.94) in the training, internal test, and external test sets, respectively, with good calibration. The DLRN demonstrated superior performance compared to the clinical model and single scores across all three sets (p < 0.05). Decision curve analysis and clinical impact curve confirmed the clinical utility of the model. Furthermore, significant enhancements in net reclassification improvement (NRI) and integrated discrimination improvement (IDI) indicated that the two scores could serve as highly valuable biomarkers for assessing LVI.
CONCLUSION: The DLRN exhibited strong predictive value for LVI in IBC, providing valuable information for individualized treatment decisions.
引用
- Zhang D, Zhou W, Lu WW, et al. Ultrasound-Based Deep Learning Radiomics Nomogram for the Assessment of Lymphovascular Invasion in Invasive Breast Cancer: A Multicenter Study. Acad Radiol. 2024. PMID: 38658211. doi:10.1016/j.acra.2024.04.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。